11β-hydroxylase deficiency: Difference between revisions
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
{{SK}} | {{SK}} 11 beta hydroxylase deficiency; 11b hydroxylase deficiency; Adrenal hyperplasia, hypertensive form; Deficiency of steroid 11-beta-monooxygenase; P450C11B1 deficiency; Steroid 11 beta hydroxylase deficiency | ||
==[[Multiple endocrine neoplasia type 1 overview|Overview]]== | ==[[Multiple endocrine neoplasia type 1 overview|Overview]]== | ||
Revision as of 20:57, 26 January 2016
Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency Microchapters |
Differentiating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
11β-hydroxylase deficiency On the Web |
American Roentgen Ray Society Images of 11β-hydroxylase deficiency |
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency |
Risk calculators and risk factors for 11β-hydroxylase deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Synonyms and keywords: 11 beta hydroxylase deficiency; 11b hydroxylase deficiency; Adrenal hyperplasia, hypertensive form; Deficiency of steroid 11-beta-monooxygenase; P450C11B1 deficiency; Steroid 11 beta hydroxylase deficiency
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency From Other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Ultrasound | CT | MRI | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies